Pure Global
NCT04467424

Recovery After Total Intravenous Anesthesia With Ketofol Versus Mixture of Ketofol and Lidocaine for Short Pediatric Surgery

TIVA With Ketofol Versus Lidoketofol for Short-term Anesthesia on Pediatric Patients; Effects on Recovery
University Hospital of Split·Phase 2·ClinicalTrials.gov·drugCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Surgical Procedure, Unspecified
Drug/Device/Intervention
ketamine, propofol
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
University Hospital of Split
Location
Split, Croatia
Timeline & enrollment
Phase
Phase 2
Start date
Jun 20, 2020
End date
Dec 18, 2020
Enrollment
200 participants
Primary outcome

Effect of TIVA With Ketofol and Ketofol Plus Lidocaine on Extubation Time in Children,Effect of TIVA With Ketofol and Ketofol Plus Lidocaine on Length of Stay in the PACU

Summary

Two hundred children aged 1-12 years undergoing short surgery will be randomized into two
 groups. Ketofol will be used for induction and maintenance of anesthesia in group l. .Ketofol
 with lidocaine will be prepared for group ll. A reducted McFarlan infusion dose will be used.
 Extubating time, duration of anesthesia, length of stay in post-anesthesia care unit (PACU)
 will be recorded.

ICD-10 classifications
Surgical procedure, unspecifiedMedical procedure, unspecifiedOther surgical proceduresDuring unspecified surgical and medical careDuring unspecified surgical and medical care
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04467424
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04467424 through Pure Global AI's free database. This Phase 2 trial is sponsored by University Hospital of Split and is currently Completed. The study focuses on Surgical Procedure, Unspecified. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.